Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127242) titled 'A Real-World Study of Deucravacitinib for the Treatment of Chinese Patients with Moderate-to-Severe Plaque Psoriasis' on June 27.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Department of Dermatology, The First Affiliated Hospital of Air Force Medical University

Condition: Psoriasis

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-07-01

Target Sample Size: Deucravacitinib treatment group:100;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=326600

Disclaimer: Curated by HT Syndication....